How pharmacies can prepare for the new vancomycin guidelines

This webinar is on-demand and can be viewed at your convenience.

Pharmacists overwhelmingly agree that recently released vancomycin dosing guidelines are important to patient safety, yet a minority have plans in place to adopt them. InsightRX surveyed 126 hospital pharmacy leaders to gauge their awareness of the guidelines, thoughts about the value of adopting them and plans to implement.

In this webinar, a panel of experts will discuss the benefits and challenges of adopting these guidelines amid the current pandemic. Tune in to learn:

  • How hospital pharmacy leaders perceive and prioritize the new vancomycin guidelines
  • How precision dosing can make a meaningful impact on patient safety
  • How to build an effective internal business case for guideline adoption



Sirj Goswami, PhD:
CEO & Co-Founder, InsightRX

Rita Jew, PharmD, FASHP:
Principal, RKJ Health Partners

Julie Giddens, PharmD, BCPS-AQID, BCIDP:
Ministry Infectious Disease Pharmacotherapy Coordinator, OSF Healthcare

Dan D’Orazio:
CEO, Sage Growth Partners

Jeffery Laux, PharmD, BCIDP:
Clinical Pharmacy Specialist, Covenant HealthCare